CHP
TAK icon

Cable Hill Partners’s Takeda Pharmaceutical TAK Stock Holding History

Cable Hill Partners’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,258
Closed -$274K – 256
2024
Q3 		$274K Buy
19,258
+1,531
+9% +$21.7K 0.03% 172
2024
Q2 		$235K Buy
+17,727
New +$235K 0.03% 183
2023
Q4 		– Sell
-25,466
Closed -$394K – 224
2023
Q3 		$394K Buy
25,466
+5,178
+26% +$80.2K 0.05% 93
2023
Q2 		$326K Sell
20,288
-2,976
-13% -$48.8K 0.04% 121
2023
Q1 		$383K Buy
23,264
+3,617
+18% +$57.6K 0.06% 104
2022
Q4 		$306K Buy
+19,647
New +$274K 0.05% 128

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cable Hill Partners's TAK Position: Q4 2024 in Review

Cable Hill Partners sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 19,258 shares — an estimated $274K sold.

Cable Hill Partners first reported a position in TAK in Q4 2022 and held it in 6 quarters. The position peaked at $394K in Q3 2023. 301 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

  • Cable Hill Partners reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Cable Hill Partners sold 19,258 Takeda Pharmaceutical shares in Q4 2024, an estimated $274K.
  • Cable Hill Partners first reported a position in Takeda Pharmaceutical in Q4 2022 and held it in 6 quarters.
  • Cable Hill Partners's Takeda Pharmaceutical position peaked at $394K in Q3 2023.
  • 301 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Cable Hill Partners's 13F filing for Q4 2024, filed 5 Feb 2025.